UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's seventh-largest company by revenue and the largest health care company by revenue. The company is ranked seventh on the 2025 Fortune Global 500.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 2026-05-22 14:59:44 | 388.67 | 6.1 | 1.59 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNH | 0000731766 | UNITEDHEALTH GROUP INC | US91324P1021 | 549300GHBMY8T5GXDE41 | 411321939 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 1 HEALTH DRIVE | EDEN PRAIRIE | MN | 55344 | UNITED STATES | US | 1-800-328-5979 | 1 HEALTH DRIVE, EDEN PRAIRIE, MN, 55344 | 1 HEALTH DRIVE, EDEN PRAIRIE, MN, 55344 | UNITED HEALTHCARE CORP | Managed healthcare | 1974 | Stephen J. Hemsley | 390,000 | https://unitedhealthgroup.com/ | 281,907,836,350 | 908,000,000 | 908,144,404 | UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's seventh-largest company by revenue and the largest health care company by revenue. The company is ranked seventh on the 2025 Fortune Global 500. | 2026-05-21 15:05:52 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 281,907,836,350 | -186,525,310,300 | -39.819 | 907,675,839 | -7,036,494 | -0.7693 |
| 2024 | 468,433,146,650 | 23,805,388,424 | 5.354 | 914,712,333 | -7,221,776 | -0.7833 |
| 2023 | 444,627,758,226 | -34,923,122,019 | -7.2825 | 921,934,109 | -10,912,493 | -1.1698 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Timothy Noel | Chief Executive Officer | 2025 | 981,827 | 0 | 15,000,506 | 1,750,000 | 469,334 | 20,201,746 |
| Patrick Conway, M.D. | Chief Executive Officer | 2025 | 980,577 | 0 | 15,000,919 | 1,750,000 | 191,028 | 19,922,610 |
| Stephen Hemsley | Chief Executive Officer | 2025 | 596,154 | 0 | 0 | 0 | 341,884 | 60,938,062 |
| Wayne Deveydt | Chief Financial Officer | 2025 | 284,615 | 1,200,000 | 8,250,430 | 1,500,000 | 97,594 | 14,582,684 |
| Christopher Zaetta | Corporate Secretary, Executive Vice President, Chief Legal Officer | 2025 | 845,192 | 0 | 12,250,835 | 925,000 | 21,270 | 15,792,307 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 390,000 |
| 2024 | 400,000 |
| 2023 | 440,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 447,567,000,000 | 400,278,000,000 | 371,622,000,000 |
| Cost Of Revenue | 50,655,000,000 | 46,694,000,000 | 38,770,000,000 |
| Gross Profit | 396,912,000,000 | 353,584,000,000 | 332,852,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 59,592,000,000 | 53,013,000,000 | 54,628,000,000 |
| Operating Expenses | 428,603,000,000 | 367,991,000,000 | 339,264,000,000 |
| Operating Income | 18,964,000,000 | 32,287,000,000 | 32,358,000,000 |
| Net Income | 12,056,000,000 | 14,405,000,000 | 22,381,000,000 |
| Earnings Per Share Basic | 13.28 | 15.64 | 24.12 |
| Earnings Per Share Diluted | 13.23 | 15.51 | 23.86 |
| Weighted Average Shares Outstanding Basic | 908,000,000 | 921,000,000 | 928,000,000 |
| Weighted Average Shares Outstanding Diluted | 911,000,000 | 929,000,000 | 938,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 24,365,000,000 | 25,312,000,000 | 25,427,000,000 |
| Marketable Securities Current | 266,000,000 | 320,000,000 | 313,000,000 |
| Accounts Receivable | 23,018,000,000 | 22,365,000,000 | 21,276,000,000 |
| Inventories | 3,300,000,000 | 3,800,000,000 | 2,800,000,000 |
| Non Trade Receivables | 29,697,000,000 | 26,089,000,000 | 17,694,000,000 |
| Other Assets Current | 9,746,000,000 | 8,212,000,000 | 6,084,000,000 |
| Total Assets Current | 90,582,000,000 | 85,779,000,000 | 78,437,000,000 |
| Marketable Securities Non Current | 202,000,000 | 161,000,000 | 246,000,000 |
| Property Plant And Equipment | 10,762,000,000 | 10,553,000,000 | 11,450,000,000 |
| Other Assets Non Current | 23,013,000,000 | 19,590,000,000 | 17,298,000,000 |
| Total Assets Non Current | 218,999,000,000 | 212,499,000,000 | 195,283,000,000 |
| Total Assets | 309,581,000,000 | 298,278,000,000 | 273,720,000,000 |
| Accounts Payable | 38,032,000,000 | 34,337,000,000 | 31,958,000,000 |
| Deferred Revenue | 3,413,000,000 | 3,317,000,000 | 3,355,000,000 |
| Short Term Debt | 6,069,000,000 | 4,545,000,000 | 4,274,000,000 |
| Other Liabilities Current | 28,046,000,000 | 27,346,000,000 | 27,072,000,000 |
| Total Liabilities Current | 114,897,000,000 | 103,769,000,000 | 99,054,000,000 |
| Long Term Debt | 72,320,000,000 | 72,359,000,000 | 58,263,000,000 |
| Other Liabilities Non Current | 18,245,000,000 | 15,939,000,000 | 14,463,000,000 |
| Total Liabilities Non Current | 92,986,000,000 | 91,918,000,000 | 75,747,000,000 |
| Total Liabilities | 207,883,000,000 | 195,687,000,000 | 174,801,000,000 |
| Common Stock | 9,000,000 | 9,000,000 | 9,000,000 |
| Retained Earnings | 95,603,000,000 | 96,036,000,000 | 95,774,000,000 |
| Accumulated Other Comprehensive Income | -2,061,000,000 | -3,387,000,000 | -7,027,000,000 |
| Total Shareholders Equity | 100,090,000,000 | 98,268,000,000 | 94,421,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 4,361,000,000 | 4,099,000,000 | 3,972,000,000 |
| Share Based Compensation Expense | 971,000,000 | 1,018,000,000 | 1,059,000,000 |
| Other Non Cash Income Expense | -1,673,000,000 | 28,000,000 | 505,000,000 |
| Change In Accounts Receivable | 764,000,000 | 1,437,000,000 | 3,114,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 4,606,000,000 | 4,140,000,000 | 2,444,000,000 |
| Change In Accounts Payable | 1,665,000,000 | 2,463,000,000 | 3,516,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 19,697,000,000 | 24,204,000,000 | 29,068,000,000 |
| Purchases Of Marketable Securities | 17,373,000,000 | 27,308,000,000 | 18,314,000,000 |
| Sales Of Marketable Securities | 9,288,000,000 | 18,514,000,000 | 7,307,000,000 |
| Acquisition Of Property Plant And Equipment | 3,622,000,000 | 3,499,000,000 | 3,386,000,000 |
| Acquisition Of Business | 4,509,000,000 | 13,408,000,000 | 10,136,000,000 |
| Other Investing Activities | 341,000,000 | 1,667,000,000 | 960,000,000 |
| Cash From Investing Activities | -8,685,000,000 | -20,527,000,000 | -15,574,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 7,916,000,000 | 7,533,000,000 | 6,761,000,000 |
| Issuance Of Common Stock | 827,000,000 | 1,846,000,000 | 1,353,000,000 |
| Repurchase Of Common Stock | 5,545,000,000 | 9,000,000,000 | 8,000,000,000 |
| Issuance Of Long Term Debt | 2,969,000,000 | 17,811,000,000 | 6,394,000,000 |
| Repayment Of Long Term Debt | 3,050,000,000 | 3,000,000,000 | 2,125,000,000 |
| Other Financing Activities | 63,000,000 | -1,645,000,000 | -1,150,000,000 |
| Cash From Financing Activities | -11,644,000,000 | -3,512,000,000 | -11,529,000,000 |
| Change In Cash | -947,000,000 | -115,000,000 | 2,062,000,000 |
| Cash At End Of Period | 24,365,000,000 | 25,312,000,000 | 25,427,000,000 |
| Income Taxes Paid | 3,714,000,000 | 4,620,000,000 | 6,078,000,000 |
| Interest Paid | 4,030,000,000 | 3,594,000,000 | 3,035,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 13.28 | 15.64 | 24.12 |
| Price To Earnings Ratio | 24.8577 | 32.344 | 21.8271 |
| Earnings Growth Rate | -15.0895 | -35.1575 | 12.3428 |
| Price Earnings To Growth Ratio | -1.6473 | -0.92 | 1.7684 |
| Book Value Per Share | 112.0022 | 111.3909 | 106.5938 |
| Price To Book Ratio | 2.9474 | 4.5413 | 4.939 |
| Ebitda | 24,133,000,000 | 27,030,000,000 | 35,677,000,000 |
| Enterprise Value | 353,763,880,000 | 517,489,060,000 | 525,674,160,000 |
| Dividend Yield | 0.0264 | 0.0162 | 0.0138 |
| Dividend Payout Ratio | 0.6566 | 0.5229 | 0.3021 |
| Debt To Equity Ratio | 0.7832 | 0.7826 | 0.6623 |
| Capital Expenditures | 4,570,000,000 | 3,202,000,000 | 5,294,000,000 |
| Free Cash Flow | 15,127,000,000 | 21,002,000,000 | 23,774,000,000 |
| Return On Equity | 0.1205 | 0.1466 | 0.237 |
| One Year Beta | 0.3089 | 0.1284 | 0.2797 |
| Three Year Beta | 0.259 | 0.4389 | 0.5348 |
| Five Year Beta | 0.4306 | 0.8192 | 0.8616 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Conway Patrick Hugh | Chief Executive Officer, Optum | 2026-04-23 | 800 | D | 17,804 |
| FLYNN TIMOTHY PATRICK | Director | 2026-04-01 | 350 | A | 10,589 |
| MONTGOMERY RICE VALERIE MD | Director | 2026-04-01 | 343 | A | 7,615 |
| Gottlieb Scott | Director | 2026-04-01 | 320 | A | 446 |
| GARCIA PAUL R | Director | 2026-04-01 | 206 | A | 3,536 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Markwayne Mullin | Senator | 2026-03-10 | Purchase | 2026-02-25 | Joint | $50,001 - $100,000 |
| Katie Britt | Senator | 2026-01-26 | Purchase | 2025-04-14 | Spouse | $1,001 - $15,000 |
| Katie Britt | Senator | 2026-01-26 | Sale (Full) | 2025-04-30 | Spouse | $1,001 - $15,000 |
| Sheldon Whitehouse | Senator | 2025-10-03 | Sale (Full) | 2025-09-04 | Self | $15,001 - $50,000 |
| Markwayne Mullin | Senator | 2025-10-01 | Purchase | 2025-09-24 | Joint | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Maria Elvira Salazar | 2026-05-08 | FL27 | Purchase | 2026-04-22 | — | $1,001 - $15,000 |
| Maria Elvira Salazar | 2026-05-08 | FL27 | Purchase | 2026-04-22 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2026-05-08 | CA31 | Purchase | 2026-04-14 | — | $1,001 - $15,000 |
| Richard Dean Dr McCormick | 2026-04-07 | GA06 | Purchase | 2026-03-19 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2026-04-07 | CA31 | Purchase | 2026-03-13 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| SUMMITRY LLC | 2026-03-31 | 373,162 | 1,379 | 270.6033 |
| GROUPAMA ASSET MANAGMENT | 2026-03-31 | 15,429,042 | 57,020 | 270.59 |
| VERUS CAPITAL PARTNERS, LLC | 2026-03-31 | 376,619 | 1,392 | 270.5596 |
| Groupe la Francaise | 2026-03-31 | 4,695,819 | 17,354 | 270.59 |
| Raab & Moskowitz Asset Management LLC | 2026-03-31 | 1,880,330 | 6,949 | 270.59 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| BUFFALO FUNDS | 2026-03-31 | Institutional Class | BUIDX | 5,600 | 1,515,304 | 0.9088 |
| BUFFALO FUNDS | 2026-03-31 | Investor Class | BUFDX | 5,600 | 1,515,304 | 0.9088 |
| BUFFALO FUNDS | 2026-03-31 | Institutional Class | BUIEX | 1,500 | 405,885 | 0.2552 |
| BUFFALO FUNDS | 2026-03-31 | Investor Class | BUFEX | 1,500 | 405,885 | 0.2552 |
| BUFFALO FUNDS | 2026-03-31 | Institutional Class | BIIGX | 4,500 | 1,217,655 | 0.7545 |